Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 InteractionJesus M. Ontoria, Steven J. Harper, Esther Torrente et al.|ACS Medicinal Chemistry Letters|2020Cited by 29
A21 Development of an Nrf2-KEAP1 protein-protein disruptor for proof of conceptAlberto Bresciani, Larry Park, Mauro Cerretani et al.|Journal of Neurology Neurosurgery & Psychiatry|2016Cited by 2